Acute cytotoxicity and apoptotic effects after L-Pam exposure in different cocultures of the proximal and distal respiratory systemPOHL, Christine; HOFMANN, Helene; MOISCH, Michaela et al.Journal of biotechnology. 2010, Vol 148, Num 1, pp 31-37, issn 0168-1656, 7 p.Conference Paper

Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosisCESARO, Simone; GAZZOLA, Maria Vittoria; MESSINA, Chiara et al.American journal of hematology. 2003, Vol 72, Num 2, pp 143-146, issn 0361-8609, 4 p.Article

Reticulate scleroderma after isolated limb perfusion with melphalanLANDAU, M; BRENNER, S; GAT, A et al.Journal of the American Academy of Dermatology. 1998, Vol 39, Num 6, pp 1011-1012, issn 0190-9622Article

Combination of the new minor groove alkylator tallimustine and melphalanTAGLIABUE, G; FILIPPINI, C; UBEZIO, P et al.European journal of cancer (1990). 1997, Vol 33, Num 2, pp 284-287, issn 0959-8049Article

Not too little, not too much—just right! (Better ways to give high dose melphalan)SHAW, P. J; NATH, C. E; LAZARUS, H. M et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 12, pp 1457-1465, issn 0268-3369, 9 p.Article

Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalanKÜHNE, Annett; KAISER, Rolf; BROCKMÖLLER, Jürgen et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 7, pp 505-517, issn 1744-6872, 13 p.Article

A stability-indicating method for the determination of melphalan and related impurity content by gradient HPLCBRIGHTMAN, K; FINLAY, G; JARVIS, I et al.Journal of pharmaceutical and biomedical analysis. 1999, Vol 20, Num 3, pp 439-447, issn 0731-7085Article

A novel melphalan polymeric prodrug: Preparation and property studyDAN LI; BO LU; XUEQIONG ZHANG et al.Carbohydrate polymers. 2014, Vol 111, pp 928-935, issn 0144-8617, 8 p.Article

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved SurvivalPALUMBO, Antonio; BRINGHEN, Sara; GRASSO, Mariella et al.Journal of clinical oncology. 2014, Vol 32, Num 7, pp 634-640, issn 0732-183X, 7 p.Article

Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantationALJITAWI, O. S; GANGULY, S; ABHYANKAR, S. H et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 8, pp 1042-1045, issn 0268-3369, 4 p.Article

Allo-SCT using BU, CY and melphalan for children with AML in second CRBEIER, R; ALBERT, M. H; HOLTER, W et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 5, pp 651-656, issn 0268-3369, 6 p.Article

Bortezomib, Melphalan, and Prednisone in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Multicenter, Open Label Phase 1/2 StudyPETRUCCI, Maria Teresa; LEVI, Anna; FOA, Robin et al.Cancer. 2013, Vol 119, Num 5, pp 971-977, issn 0008-543X, 7 p.Article

Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioningDECOOK, U; THOMA, M; HUNEKE, T et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 5, pp 708-714, issn 0268-3369, 7 p.Article

Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCTKHALED, Y; AL-HAZZOURI, A; MIZRACHI, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 310-311, issn 0268-3369, 2 p.Article

The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma modelTEN HAGEN, Timo L. M; SEYNHAEVE, Ann L. B; DE WIEL-AMBAGTSHEER, Gisela Aan et al.International journal of cancer (Print). 2013, Vol 132, Num 11, pp 2694-2704, issn 0020-7136, 11 p.Article

Le rôle du melphalan dans le traitement du myélome multiple = The role of melphalan in the treatment of multiple myelomaHAROUSSEAU, Jean-Luc.La Revue de gériatrie. 2012, Vol 37, Num 2, pp 99-109, issn 0397-7927, 11 p.Article

A Randomized Phase 2 Trial of a Preparative Regimen of Bortezomib, High-Dose Melphalan, Arsenic Trioxide, and Ascorbic AcidSHARMA, Manish; KHAN, Hassan; HOSING, Chitra M et al.Cancer. 2012, Vol 118, Num 9, pp 2507-2515, issn 0008-543X, 9 p.Article

Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From RetinoblastomaGHASSEMI, Fariba; SHIELDS, Carol L.Archives of ophthalmology (1960). 2012, Vol 130, Num 10, pp 1268-1271, issn 0003-9950, 4 p.Article

Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma: A reviewJABBOUR, Pascal; CHALOUHI, Nohra; TJOUMAKARIS, Stavropoula et al.Journal of neurosurgery. Pediatrics. 2012, Vol 10, Num 3, pp 175-181, issn 1933-0707, 7 p.Article

Single-agent high-dose melphalan followed by auto-SCT for relapsed and refractory Hodgkin lymphoma in children and adolescentsGUILCHER, Gmt; RIZZUTI, F. A; LEWIS, V. A et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 3, pp 395-398, issn 0268-3369, 4 p.Article

Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndromeJIAN LI; WEI ZHANG; LI JIAO et al.Blood. 2011, Vol 117, Num 24, pp 6445-6449, issn 0006-4971, 5 p.Article

High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AMLO'MEARA, A; PABST, T; STERN, M et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 5, pp 636-640, issn 0268-3369, 5 p.Article

High-throughput analysis of DNA interstrand crosslinks in human peripheral blood mononuclear cells by automated reverse FADU assayDEBIAK, Małgorzata; PANAS, Alicja; STEINRITZ, Dirk et al.Toxicology (Amsterdam). 2011, Vol 280, Num 1-2, pp 53-60, issn 0300-483X, 8 p.Article

Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasmaSPARIDANS, Rolf W; MARTENS, Irene; VALKENBURG-VAN IERSEL, Liselot B. J et al.Journal of chromatography. B. 2011, Vol 879, Num 21, pp 1851-1856, issn 1570-0232, 6 p.Article

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysisKAPOOR, P; RAJKUMAR, S. V; KUMAR, S et al.Leukemia. 2011, Vol 25, Num 4, pp 689-696, issn 0887-6924, 8 p.Article